by Katrina Carr | Mar 31, 2019 | Biomarkers
B7-H3 stands out as future SCLC target BY CHRISTINE KILGORE MDedge News FROM THE JOURNAL FOR IMMUNOTHERAPY OF CANCER About two out of three patients with small cell lung cancer (SCLC) express B7-H3, a B7 family ligand that may one day serve as a therapeutic target,...
